Graf Akcie MEDS (). Diskuze k akciím MEDS. Aktuální informace MEDS.

Základní informace o společnosti (Akcie MEDS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 37.46M
Hodnota podniku (EV) N/A
Tržby 13.278M
EBITDA N/A
Zisk -5.40
Růst v tržbách Q/Q -71.21 %
Růst v tržbách Y/Y 3.71 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -6.59
EV/Sales 2.52
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 2.82
P/FCF 106.28
Price/Book 4.32
Účetní hodnota na akcii 1.05
Hotovost na akcii 0.72
FCF vůči ceně 0.94 %
Počet zaměstnanců 43
Tržba na zaměstnance 308.792k
Profit margin -14.81 %
Operating margin -40.47 %
Gross margin 33.33 %
EBIT margin -40.47 %
EBITDA margin 3.50 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 357.14 %
EPS - Očekávaný růst příští rok -750.00 %
Return on assets -56.53 %
Return on equity -64.53 %
ROIC -32.63 %
ROCE -89.04 %
Dluhy/Equity 0.13
Čistý dluh/EBITDA -30.55
Current ratio 7.59
Quick Ratio 7.43
Volatilita 4.40
Beta 1.16
RSI 34.50
Cílová cena analytiků 11
Známka akcie (dle analytiků) N/A
Insider ownership 59.73 %
Institutional ownership 13.79 %
Počet akcií 8.161M
Procento shortovaných akcií 1.66 %
Short ratio 0.66 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2019
Země United States

Finanční výsledky akcie MEDS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$7.436$3.832$2.931$2.482$2.913$1.496$0.956$0.806
Cost Of Goods Sold$2.566$0.449--$0.19$0.44$0.944$0.69
Gross Profit$4.871$3.383$2.931$2.482$2.723$1.056$0.012$0.116
Research And Development Expenses--------
SG&A Expenses$4.377$3.47$2.536$3.489$2.86$2.488$2.096$0.267
Other Operating Income Or Expenses$-0.369-------
Operating Expenses$7.311$3.919$2.536$3.489$3.05$2.928$3.04$0.957
Operating Income$0.125$-0.088$0.395$-1.007$-0.137$-1.432$-2.084$-0.151
Total Non-Operating Income/Expense$-0.41$0.097$-0.106$-0.166$-0.12$-0.581$-0.007-
Pre-Tax Income$-0.284$0.009$0.289$-1.173$-0.257$-2.012$-2.091$-0.151
Income Taxes--------
Income After Taxes$-0.284$0.009$0.289$-1.173$-0.257$-2.012$-2.091$-0.151
Other Income--------
Income From Continuous Operations$-0.284$0.009$0.289$-1.173$-0.257$-2.012$-2.091$-0.151
Income From Discontinued Operations---$-1.587$-0.861---
Net Income$-0.284$0.009$0.289$-2.76$-1.117$-2.012$-2.091$-0.151
EBITDA$0.22$-0.088$0.484$-0.896$-0.032$-1.427$-2.08$-0.148
EBIT$0.125$-0.088$0.395$-1.007$-0.137$-1.432$-2.084$-0.151
Basic Shares Outstanding6555552-
Shares Outstanding6665552-
Basic EPS$-0.05-$0.06$-0.54$-0.24$-0.42$-0.90-
EPS - Earnings Per Share$-0.05-$0.06$-0.54$-0.24$-0.42$-0.90-
# 2020 2019 2018 2017 2016 2015
Current Ratio7.30191.7041.15630.22860.29772.2004
Long-term Debt / Capital0.05150.38224.3862-0.0093--
Debt/Equity Ratio0.05430.9993-2.1362-0.68061.4954-
Gross Margin65.500188.280910010093.48270.5896
Operating Margin1.684-2.286613.4786-40.5856-4.7062-95.6721
EBIT Margin1.684-2.286613.4786-40.5856-4.7062-95.6721
EBITDA Margin2.9579-2.282616.5028-36.1015-1.0943-95.3513
Pre-Tax Profit Margin-3.82490.23599.8586-47.2672-8.8096-134.4744
Net Profit Margin-3.82490.23599.8586-111.2117-38.3579-134.4744
Asset Turnover1.33471.72014.74727.36191.43641.2243
Inventory Turnover Ratio45.19835.6155---9.4778
Receiveable Turnover9.38868.83669.17558.29748.21034.2869
Days Sales In Receivables38.876841.305639.779743.989644.456685.1436
ROE - Return On Equity-6.86991.07-92.6425102.1821-96.0919-301.0054
Return On Tangible Equity-8.33067.6145-92.6426102.182-96.0921-301.0053
ROA - Return On Assets-5.10510.405746.8007-347.9752-12.654-164.6357
ROI - Return On Investment-6.51580.6611313.706103.1331-96.092-301.0053
Book Value Per Share0.63320.1522-0.0585-0.21750.0510.1282
Operating Cash Flow Per Share-0.0230.01670.126-0.11310.23140.1452
Free Cash Flow Per Share-0.03430.01410.126-0.11310.23140.1452